Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report ; volume:21 ; number:1 ; day:5 ; month:6 ; year:2021 ; pages:1-8 ; date:12.2021
BMC ophthalmology ; 21, Heft 1 (5.6.2021), 1-8, 12.2021
- Urheber
-
Lambert, Ine
Fasolino, Giuseppe
Awada, Gil
Kuijpers, Robert
ten Tusscher, Marcel
Neyns, Bart
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-021-02011-4
- URN
-
urn:nbn:de:101:1-2021092921072387885269
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lambert, Ine
- Fasolino, Giuseppe
- Awada, Gil
- Kuijpers, Robert
- ten Tusscher, Marcel
- Neyns, Bart
- SpringerLink (Online service)
Ähnliche Objekte (12)
Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Acute exudative polymorphous paraneoplastic vitelliform maculopathy (AEPPVM) associated with choroidal melanoma
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report
AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report
Acute visual loss after ipilimumab treatment for metastatic melanoma
Metastatic melanoma: an unexpected cause of acute liver failure
Paracentral Acute Middle Maculopathy in Migraines with Aura
Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia
Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Acute exudative polymorphous paraneoplastic vitelliform maculopathy (AEPPVM) associated with choroidal melanoma
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report
AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report
Acute visual loss after ipilimumab treatment for metastatic melanoma
Metastatic melanoma: an unexpected cause of acute liver failure
Paracentral Acute Middle Maculopathy in Migraines with Aura
Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia
Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Acute exudative polymorphous paraneoplastic vitelliform maculopathy (AEPPVM) associated with choroidal melanoma
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report
AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report
Acute visual loss after ipilimumab treatment for metastatic melanoma
Metastatic melanoma: an unexpected cause of acute liver failure
Paracentral Acute Middle Maculopathy in Migraines with Aura